Celebrating 10 years of success for Infusion
As the business took off, more space was needed, and the company moved in 2009 to “real” office space just up the road in Haddam, CT, across the street from the Connecticut River, eventually employing a staff of 10 that year. A year later, in 2010, Infusion had doubled in size and became part of the UDG/Ashfield family. Infusion continued to grow at a steady pace into new therapeutic areas with more clients and employees, and in October 2016, Infusion left its country setting and moved into larger corporate offices in downtown Middletown, CT. Our staff now comprises 45 people and includes account executives, medical writers, scientific directors, medical editors, and graphic designers. Three of the four original employees still work at Infusion (Matt, Angela, and Rick Kemmerer), and many of us have been here 5+ years. It’s the challenge of the work and the quality of the people we work with that gets us into the office every day and keeps us here long-term. Some 90% of our scientific staff have advanced degrees, and our management team has 18+ years of experience in healthcare communication; our scientific team 10+ years; our core delivery team 10+ years; and client services 8+ years. Heather Sylvestro, our Director of Graphics and Production, is an award-winning designer, having been recognised several times by professional advertising/graphics industry groups for her designs and having had her design chosen as the artwork for the 2014 annual meeting of th...
Publication date: Available online 31 May 2020Source: Neurología (English Edition)Author(s): F. Castillo-Álvarez, P. Pérez-Matute, J.A. Oteo, M.E. Marzo-Sola
Publication date: Available online 31 May 2020Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyAuthor(s): Daniella Reis Barbosa Martelli, Hercílio Martelli Júnior
Findings on neuroimaging suggest that for patients with progressive multiple sclerosis, constraint-induced movement therapy leads to changes in white and gray matter.Medscape Medical News
An experimental gene therapy for hemophilia A from BioMarin Pharmaceutical Inc. — promising a one-shot fix for the genetic cause of the bleeding disorder — continues to hold patients' bleeds to less than one a year after four years. The results of the ongoing study are important as San Rafael-based BioMarin's (NASDAQ: BMRN) gene therapy, called Roctavian and known scienti fically as valoctogene roxaparvovec, nears an Aug. 21 decision date from the Food and Drug Administration. If approved, it…
The two largest pharmacy benefit managers (PBMs), CVS Caremark and Express Scripts, have once againincreased the number of medicines on their standard formulary exclusion lists. Medicines excluded from formularies treat many chronic and complex conditions, including depression, diabetes and multiple sclerosis. As these PBMs control over half of the market combined, these changes have widespread implications for patients across the country.
Condition: Relapsing Multiple Sclerosis Interventions: Drug: SAR442168; Drug: Teriflunomide HMR1726; Drug: Placebo to match SAR442168; Drug: Placebo to match Teriflunomide Sponsor: Sanofi Not yet recruiting
Condition: Multiple Sclerosis Intervention: Drug: TERIFLUNOMIDE Sponsor: Sanofi Not yet recruiting
Contributors : Pascal Barbry ; Agnes Paquet ; Kevin Lebrigand ; Nicolas Pons ; Ignacio CaballeroSeries Type : Expression profiling by high throughput sequencingOrganism : Sus scrofaChronic infection of the lungs by bacteria such as Pseudomonas aeruginosa plays an important role in the natural history of Cystic Fibrosis (CF). Altered mucin secretions and glycosylations are hallmarks of bacterial infections but their exact contributions to the development of chronic infection and/or inflammation remain to be established. We studied the lung environment in newborn CFTR-/- pigs, which closely mirrors the human CF phenotype at ...
Publication date: Available online 30 May 2020Source: Respiratory Medicine Case ReportsAuthor(s): José Dario Portillo Miño, Esteban Efrén Cerón
Publication date: Available online 26 May 2020Source: NeuroImage: ClinicalAuthor(s): Kl. West, Dk. Sivakolundu, Gb. Maruthy, Md. Zuppichini, P. Liu, Bp. Thomas, Js. Spence, H. Lu, Dt. Okuda, B. Rypma